Argon beam coagulation as an adjuvant for local control of giant cell tumor

Keyphrases

• Adjuvant Therapy 100%
• Local Control 100%
• Giant Cell Tumor 100%
• Argon Beam Coagulation 100%
• Argon Beam Coagulator 60%
• Treatment Options 40%
• Disease-free Survival 20%
• Survival Estimation 20%
• Local Recurrence 20%
• Short Form 36 (SF-36) 20%
• Functional Outcome 20%
• Recurrence Rate 20%
• Low Dose Rate 20%
• Functional Consequences 20%
• Patient Outcomes 20%
• Kaplan-Meier 20%
• Curettage 20%
• Arthritis 20%
• Osseous 20%
• Giant Cell Tumor of Bone 20%
• Cementation 20%
• Functional Perception 20%
• Mental Perception 20%
• 95% Confidence Interval 20%
• Radiographic Evidence 20%
• Musculoskeletal Tumor Society Score 20%
• Soft Tissue Recurrence 20%

Nursing and Health Professions

• Adjuvant Therapy 100%
• Giant Cell Tumor 100%
• Argon Plasma Coagulation 100%
• Recurrent Disease 60%
• Argon Laser 60%
• Neoplasm 20%
• Confidence Interval 20%
• Short Form 36 20%
• Recurrence Risk 20%
• Vascular Guide Wire 20%
• Disease Free Survival 20%
• Arthritis 20%
• Adjuvant 20%
• Curettage 20%
• Musculoskeletal System 20%
• Cementation 20%
• Osteoclastoma 20%

Medicine and Dentistry

• Adjuvant Therapy 100%
• Giant Cell Tumor 100%
• Argon Plasma Coagulation 100%
• Recurrent Disease 60%
• Treatment Option 40%
• Disease Free Survival 20%
• Survival Estimate 20%
• Recurrence Risk 20%
• Short Form 36 20%
• Musculoskeletal Tumor 20%
• Adjuvant 20%
• Arthritis 20%
• Curettage 20%
• Osteoclastoma 20%
• Cementation 20%